CAIRDAC Appoints MedTech Executive Raymond W. Cohen as Board Chairman CAIRDAC, SA, a pre-revenue medical technology company developing an autonomous, leadless and self-powered cardiac pacemaker, has appointed Raymond W. Cohen as chairman of its board of directors. The company said…
Genialis and Inventia Life Science Collaborate to Advance Patient-Relevant Pancreatic Cancer Models Genialis, a therapeutic intelligence company, and Inventia Life Science, a developer of advanced 3D cell model technologies, have announced a collaboration aimed at improving how new pancreatic cancer…
ApalyRx and Vida Health Partner to Expand Cost-Effective, Integrated Weight-Loss Care for Employers ApalyRx, a pharmacy technology platform designed to assess prescriptions in real time and route them to the lowest-cost fulfillment channel available under a health plan benefit, has…
StandardX Raises £10 Million to Build Scalable Isotope Refinery for Medicine and Fusion Energy StandardX, a UK-headquartered European deep technology company founded in 2025, has raised £10 million in seed funding to develop what it describes as the world’s first…
Medincell Partner Teva Presents New Data on Investigational Olanzapine LAI and UZEDY at Psych Congress 2026 Medincell’s partner Teva Pharmaceuticals presented new clinical and real-world data on two long-acting injectable (LAI) antipsychotic treatments incorporating Medincell’s proprietary BEPO® drug delivery technology,…
Novartis’ Cosentyx Receives Positive CHMP Opinion for Polymyalgia Rheumatica in Europe Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending marketing authorization for Cosentyx® (secukinumab)…
Merck Launches “Your Hive of Whole Health” Program to Support Whole-Person Well-Being for People Living With HIV Merck (NYSE: MRK), known as MSD outside the United States and Canada, has launched Your Hive of Whole Health, a new multi-year educational…
Sensorion to Host SENS-601 Program Day on GJB2-Related Hearing Loss Gene Therapy Sensorion (FR001401A9Z0 – ALSEN), a clinical-stage biotechnology company focused on developing novel therapies designed to restore, treat, and prevent hearing loss disorders, has announced registration and connection details…
Takeda Awards $22.2 Million to Four Global CSR Partners to Strengthen Climate-Resilient Health Systems Takeda (TSE: 4502/NYSE: TAK) has announced a total commitment of $22.2 million to four new Global Corporate Social Responsibility (CSR) partners as part of its continuing…
AptarGroup and MGH’s Alice Stanton Launch Research Collaboration to Advance Nose-to-Brain Drug Delivery AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies and consumer product dispensing, has announced a new research collaboration with Alice Stanton,…
AESARA Appoints Denise Sánchez as Vice President of Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, has announced the appointment of Denise Sánchez, JD, MS, MA, as Vice President, Regulatory Counsel & Compliance Strategies. Sánchez brings…
Retension Pharmaceuticals Forms Scientific Advisory Board to Support RTN-001 Phase 2b Hypertension Development Retension Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing medicines for hypertension and other cardiovascular diseases, has announced the formation of a Scientific Advisory Board (SAB)…